Literature DB >> 28385358

Atrial fibrillation risk in metabolically healthy obesity: A nationwide population-based study.

HyunJung Lee1, Eue-Keun Choi2, Seung-Hwan Lee3, Kyung-Do Han4, Tae-Min Rhee1, Chan-Soon Park1, So-Ryoung Lee1, Won-Seok Choe1, Woo-Hyun Lim5, Si-Hyuck Kang6, Myung-Jin Cha1, Seil Oh1.   

Abstract

BACKGROUND: Metabolically healthy obese (MHO) individuals are reported to have a marginal increase in cardiovascular risk; however, their atrial fibrillation (AF) risk is unclear. We aimed to assess AF risk in MHO individuals and identify whether AF development is associated with obesity or influenced by metabolic comorbidities.
METHODS: A retrospective cohort of 389,321 individuals (age, 45.6±14.5years; male, 52.1%) was extracted from the Korean National Health Insurance sample database between 2004 and 2006 and followed-up for new-onset AF until 2013. Subjects with diabetes mellitus, hypertension, and/or dyslipidemia were classified as "metabolically unhealthy." The cohort was stratified into four groups according to obesity and metabolic healthiness: metabolically healthy non-obese (MHNO), metabolically unhealthy non-obese (MUNO), MHO, and metabolically unhealthy obese (MUO).
RESULTS: AF was newly diagnosed in 5106 (1.3%) individuals during a mean follow-up of 7.5±1.5years. The AF incidence rates for the MHNO, MUNO, MHO, and MUO groups were 0.76, 2.66, 1.10, and 2.88 per 1000 person-years, respectively. Compared with the MHNO group, the MHO group had increased AF risk (adjusted hazard ratio, 1.30; 95% CI, 1.14-1.48) on multivariate analysis. One fourth of the MHO cohort became metabolically unhealthy, contributing to increased AF risk. Obesity was an independent risk factor for AF, and increased AF risk by 20%. Metabolic unhealthiness increased AF risk by around 40%, and of its components, hypertension contributed the most.
CONCLUSIONS: MHO individuals are at increased risk for AF development, and obesity was independently associated with elevated AF risk.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Epidemiology; Metabolically healthy obesity; Obesity; Risk factors

Mesh:

Year:  2017        PMID: 28385358     DOI: 10.1016/j.ijcard.2017.03.103

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  24 in total

1.  Transition of Metabolic Phenotypes and Risk of Atrial Fibrillation According to BMI: Kailuan Study.

Authors:  Maoxiang Zhao; Wenjuan Du; Qianqian Zhao; Yating Chen; Bin Li; Zhonghui Xie; Zihao Fu; Nan Zhang; Xiaowei Cheng; Xiaoqian Li; Siyu Yao; Miao Wang; Chi Wang; Shouling Wu; Hao Xue; Yang Li
Journal:  Front Cardiovasc Med       Date:  2022-06-28

2.  Modifiable Risk Factors and Atrial Fibrillation: the Quest for a Personalized Approach.

Authors:  Lavinia-Lucia Matei; Calin Siliste; Dragos Vinereanu
Journal:  Maedica (Bucur)       Date:  2021-03

3.  Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants: A nationwide population-based study.

Authors:  So-Ryoung Lee; Eue-Keun Choi; Kyung-Do Han; Myung-Jin Cha; Seil Oh; Gregory Y H Lip
Journal:  PLoS One       Date:  2017-12-20       Impact factor: 3.240

4.  A U-shaped relationship of body mass index on atrial fibrillation recurrence post ablation: A report from the Guangzhou atrial fibrillation ablation registry.

Authors:  Hai Deng; Alena Shantsila; Pi Guo; Tatjana S Potpara; Xianzhang Zhan; Xianhong Fang; Hongtao Liao; Yang Liu; Wei Wei; Lu Fu; Shulin Wu; Yumei Xue; Gregory Y H Lip
Journal:  EBioMedicine       Date:  2018-08-30       Impact factor: 8.143

5.  Association of Variability in Body Mass Index and Metabolic Health With Cardiometabolic Disease Risk.

Authors:  Todd R Sponholtz; Edwin R van den Heuvel; Vanessa Xanthakis; Ramachandran S Vasan
Journal:  J Am Heart Assoc       Date:  2019-04-02       Impact factor: 5.501

6.  Incidence of Prostate Cancer according to Metabolic Health Status: a Nationwide Cohort Study.

Authors:  Jong Wook Kim; Sun Tae Ahn; Mi Mi Oh; Du Geon Moon; Kyungdo Han; Hong Seok Park
Journal:  J Korean Med Sci       Date:  2019-01-31       Impact factor: 2.153

7.  Mortality and causes of death in patients with atrial fibrillation: A nationwide population-based study.

Authors:  Euijae Lee; Eue-Keun Choi; Kyung-Do Han; HyunJung Lee; Won-Seok Choe; So-Ryoung Lee; Myung-Jin Cha; Woo-Hyun Lim; Yong-Jin Kim; Seil Oh
Journal:  PLoS One       Date:  2018-12-26       Impact factor: 3.240

8.  Risk of ischemic stroke in metabolically healthy obesity: A nationwide population-based study.

Authors:  Hyun-Jung Lee; Eue-Keun Choi; Seung-Hwan Lee; Yong-Jin Kim; Kyung-Do Han; Seil Oh
Journal:  PLoS One       Date:  2018-03-30       Impact factor: 3.240

9.  Hospitalization for heart failure incidence according to the transition in metabolic health and obesity status: a nationwide population-based study.

Authors:  You-Bin Lee; Da Hye Kim; Seon Mee Kim; Nan Hee Kim; Kyung Mook Choi; Sei Hyun Baik; Yong Gyu Park; Kyungdo Han; Hye Jin Yoo
Journal:  Cardiovasc Diabetol       Date:  2020-06-13       Impact factor: 9.951

10.  High variability in bodyweight is associated with an increased risk of atrial fibrillation in patients with type 2 diabetes mellitus: a nationwide cohort study.

Authors:  Hyun-Jung Lee; Eue-Keun Choi; Kyung-Do Han; Da Hye Kim; Euijae Lee; So-Ryoung Lee; Seil Oh; Gregory Y H Lip
Journal:  Cardiovasc Diabetol       Date:  2020-06-13       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.